Ind-Swift Laboratories (NSE:INDSWFTLAB) Cyclically Adjusted Book per Share: ₹206.04 (As of Mar. 2026)


NSE:INDSWFTLAB Ind-Swift Laboratories Ltd NSE:INDSWFTLAB
48 GF Score
Price ₹214.16
GF Value ₹37.06
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Ind-Swift Laboratories Cyclically Adjusted Book per Share?

Ind-Swift Laboratories NSE:INDSWFTLAB +3.85% 48 Cyclically Adjusted Book per Share is ₹206.04 as of Mar. 2026. GuruFocus rates NSE:INDSWFTLAB with a GF Score™ of 48/100 and a GF Value™ of ₹37.06 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Ind-Swift Laboratories's adjusted book value per share for the three months ended in Mar. 2026 was ₹159.382. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹206.04 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Ind-Swift Laboratories's average Cyclically Adjusted Book Growth Rate was -7.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-05), Ind-Swift Laboratories's current stock price is ₹214.16. Ind-Swift Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ₹206.04. Ind-Swift Laboratories's Cyclically Adjusted PB Ratio of today is 1.04.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Ind-Swift Laboratories was 1.04. The lowest was 0.32. And the median was 0.47.


Ind-Swift Laboratories  (NSE:INDSWFTLAB) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Ind-Swift Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=214.16/206.04
=1.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Ind-Swift Laboratories was 1.04. The lowest was 0.32. And the median was 0.47.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Ind-Swift Laboratories Cyclically Adjusted Book per Share Related Terms


Ind-Swift Laboratories Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Ind-Swift Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ind-Swift Laboratories Cyclically Adjusted Book per Share Chart

Ind-Swift Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 221.75 206.04

Ind-Swift Laboratories Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 221.75 216.99 0.00 206.04

NSE:INDSWFTLAB vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ind-Swift Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ind-Swift Laboratories Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ind-Swift Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Ind-Swift Laboratories's Cyclically Adjusted PB Ratio falls into.


NSE:INDSWFTLAB
48GF Score
Ind-Swift Laboratories Ltd NSE:INDSWFTLAB
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ind-Swift Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ind-Swift Laboratories's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=159.382/164.2724*164.2724
=159.382

Current CPI (Mar. 2026) = 164.2724.

Ind-Swift Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201206 0.000 79.567 0.000
201209 379.690 82.244 758.383
201212 0.000 83.774 0.000
201303 217.327 85.687 416.642
201403 177.046 91.425 318.117
201503 145.141 97.163 245.389
201603 126.315 102.518 202.404
201703 118.758 105.196 185.451
201803 121.256 109.786 181.434
201806 0.000 111.317 0.000
201809 0.000 115.142 0.000
201812 0.000 115.142 0.000
201903 123.571 118.202 171.734
201906 0.000 120.880 0.000
201909 120.057 123.175 160.114
201912 0.000 126.235 0.000
202003 108.422 124.705 142.823
202006 0.000 127.000 0.000
202009 110.876 130.118 139.980
202012 0.000 130.889 0.000
202103 102.139 131.771 127.332
202106 0.000 134.084 0.000
202109 109.477 135.847 132.385
202112 0.000 138.161 0.000
202203 101.710 138.822 120.357
202206 0.000 142.347 0.000
202209 109.363 144.661 124.189
202212 0.000 145.763 0.000
202303 115.411 146.865 129.091
202306 0.000 150.280 0.000
202309 123.600 151.492 134.027
202312 0.000 152.924 0.000
202403 137.439 153.035 147.532
202406 0.000 155.789 0.000
202409 171.196 157.882 178.125
202412 0.000 158.323 0.000
202503 193.504 157.552 201.758
202509 160.209 162.289 162.167
202512 0.000 163.281 0.000
202603 159.382 164.272 159.382

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₹206.04 mean?
Ind-Swift Laboratories (NSE:INDSWFTLAB) has a Cyclically Adjusted Book per Share of ₹206.04 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Ind-Swift Laboratories and its competitors.
Is Ind-Swift Laboratories' Cyclically Adjusted Book per Share too high?
Ind-Swift Laboratories' current Cyclically Adjusted Book per Share is ₹206.04. Overall, Ind-Swift Laboratories has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ind-Swift Laboratories' Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Ind-Swift Laboratories' Cyclically Adjusted Book per Share of ₹206.04 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Ind-Swift Laboratories and its competitors. Ind-Swift Laboratories's current Cyclically Adjusted Book per Share is ₹206.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ind-Swift Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Ind-Swift Laboratories (NSE:INDSWFTLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹37.06, compared to a current price of ₹214.16 — trading 477.9% above its estimated fair value. The current Cyclically Adjusted Book per Share is ₹206.04. Ind-Swift Laboratories' overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Ind-Swift Laboratories (NSE:INDSWFTLAB), the current Cyclically Adjusted Book per Share is ₹206.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ind-Swift Laboratories (NSE:INDSWFTLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Ind-Swift Laboratories stock appears to be overvalued. The current stock price of ₹214.16 is trading 477.9% above its estimated GF Value™ of ₹37.06. GuruFocus considers Ind-Swift Laboratories to be Significantly Overvalued.

Key valuation signals for NSE:INDSWFTLAB:

  • Cyclically Adjusted Book per Share: ₹206.04
  • GF Value™: ₹37.06 vs. price of ₹214.16 (477.9% above fair value)
  • GF Score™: 48/100 with 4 warning signs

No single metric tells the full story. See the NSE:INDSWFTLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ind-Swift Laboratories Business Description

Other Exchanges 532305:India
Address SCO 850, NAC, Shivalik Enclave, Manimajra, Chandigarh, PB, IND, 160101
Ind-Swift Laboratories Ltd is involved in manufacturing Active Pharmaceutical Ingredients (API), Intermediates, and formulations. The company serves various therapeutic segments, including Cardiovascular health, Antihistamines, Antidiabetics, Antipsychotics, Parkinson's disease, Antineoplastics, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitors. It operates solely in the pharmaceutical products sector. Geographically, the company supplies both domestic and international markets, with the majority of its revenue coming from outside India.
48GF Score

Get the complete analysis for NSE:INDSWFTLAB

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹214.16
Price
₹37.06
GF Value